These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10882018)

  • 1. Synthesis, hydroxyl radical production and cytotoxicity of analogues of bleomycin.
    Highfield JA; Mehta LK; Parrick J; Wardman P
    Bioorg Med Chem; 2000 May; 8(5):1065-73. PubMed ID: 10882018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and properties of prodrugs activated in hypoxia to give bleomycin analogues.
    Highfield JA; Mehta LK; Parrick J; Candeias LP; Wardman P
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2609-14. PubMed ID: 9873590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation and DNA binding properties of novel bleomycin analogues.
    Xu ZD; Wang M; Xiao SL; Liu CL; Yang M
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2595-9. PubMed ID: 12852974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chelating, DNA-binding and DNA-cleaving properties of a synthetic model for bleomycin.
    Kenani A; Lohez M; Houssin R; Helbecque N; Bernier JL; Lemay P; Hénichart JP
    Anticancer Drug Des; 1987 Aug; 2(1):47-59. PubMed ID: 2452643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analogues of bleomycin: synthesis of conformationally rigid methylvalerates.
    Rishel MJ; Hecht SM
    Org Lett; 2001 Sep; 3(18):2867-9. PubMed ID: 11529777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of iron, copper, cobalt, and their chelators on the cytotoxicity of bleomycin.
    Lin PS; Kwock L; Hefter K; Misslbeck G
    Cancer Res; 1983 Mar; 43(3):1049-53. PubMed ID: 6186368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis of bleomycin A(5) and three monosaccharide analogues: exploring the role of the carbohydrate moiety in RNA cleavage.
    Thomas CJ; Chizhov AO; Leitheiser CJ; Rishel MJ; Konishi K; Tao ZF; Hecht SM
    J Am Chem Soc; 2002 Nov; 124(44):12926-7. PubMed ID: 12405801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bleomycin amplification assay in V79 cells predicts frameshift mutagenicity of intercalative agents.
    Snyder RD; Diehl MS
    Mutagenesis; 2000 May; 15(3):203-5. PubMed ID: 10792011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-phase synthesis of bleomycin group antibiotics. Construction of a 108-member deglycobleomycin library.
    Leitheiser CJ; Smith KL; Rishel MJ; Hashimoto S; Konishi K; Thomas CJ; Li C; McCormick MM; Hecht SM
    J Am Chem Soc; 2003 Jul; 125(27):8218-27. PubMed ID: 12837092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermia and bleomycin schedules on V79 Chinese hamster cell cytotoxicity in vitro.
    Lin PS; Hefter K; Jones M
    Cancer Res; 1983 Oct; 43(10):4557-61. PubMed ID: 6192905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of key analogs of bleomycin A2 that permit a systematic evaluation of the linker region: identification of an exceptionally prominent role for the L-threonine substituent.
    Boger DL; Colletti SL; Teramoto S; Ramsey TM; Zhou J
    Bioorg Med Chem; 1995 Sep; 3(9):1281-95. PubMed ID: 8564421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of bleomycin cytotoxicity by glutathione depletion or elevation.
    Russo A; Mitchell JB; McPherson S; Friedman N
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1675-8. PubMed ID: 6207156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleomycin and misonidazole cytotoxicity.
    Korbelik M; Palcic B; Skarsgard LD
    Br J Cancer; 1985 Apr; 51(4):499-504. PubMed ID: 2579666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature dependence of adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in vitro.
    Herman TS
    Cancer Res; 1983 Feb; 43(2):517-20. PubMed ID: 6184147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-synthesis and tumor growth inhibitions by AGGA, a bleomycin-amsacrine hybrid derivative.
    Bailly C; Pommery N; Henichart JP
    Cancer Lett; 1988 Jan; 38(3):321-8. PubMed ID: 2450638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin cytotoxicity is prevented by superoxide dismutase in vitro.
    Cunningham ML; Ringrose PS; Lokesh BR
    Cancer Lett; 1983 Dec; 21(2):149-53. PubMed ID: 6197159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway.
    Tounekti O; Kenani A; Foray N; Orlowski S; Mir LM
    Br J Cancer; 2001 May; 84(9):1272-9. PubMed ID: 11336481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pingyangmycin and Bleomycin Share the Same Cytotoxicity Pathway.
    He Y; Lan Y; Liu Y; Yu H; Han Z; Li X; Zhang L
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27376254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-phase synthesis of deglycobleomycin and bleomycin.
    Leitheiser CJ; Hecht SM
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):827-37. PubMed ID: 14758754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformationally constrained analogues of bleomycin A5.
    Rishel MJ; Thomas CJ; Tao ZF; Vialas C; Leitheiser CJ; Hecht SM
    J Am Chem Soc; 2003 Aug; 125(34):10194-205. PubMed ID: 12926941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.